Rule 37, The Drugs and Cosmetics Rules, 1945: Packing of patent or proprietary medicine
The Drugs and Cosmetics Rules, 1945 - Rule 37
Text of rule 37
Packing of patent or proprietary medicine
[37. Packing of patent or proprietary medicine. —Patent or proprietary
medicines shall be imported in containers intended for retail sale:
4
[Provided that such medicines may be imported in bulk containers by any
person who holds a licence to manufacture, if such person has obtained permission in
writing to import such medicines from the licensing authority at least three months prior
to the date of import and the imports are made within a period of twelve months from
the date of issue of such permission].]
38. Statement to accompany imported drugs. All consignments of drugs sought to be
imported shall be accompanied by an invoice or other statement showing the name and
address of the manufacturer and the name and quantities of the drugs.
39. Documents to be supplied to the Customs Collector. Before drugs for the import
of which a licence is not required are imported a declaration signed by or on behalf of the
manufacturer or by or on behalf of the importer that the drugs comply with the provisions
of Chapter III of the Drugs and Cosmetics Act, 1940 and the Rules thereunder shall be
supplied to the Customs Collector.
1. Ins. by G.S.R 604 (E), dt. 24-8-2001.
2. Ins. by Notfn. No.F-1-36/54-D.S., (SRO 560), dt. 3-3-1955.
3. Ins. by Notfn. No.F-1-3/51-D.S., (SRO 3262), dt. 15-10-1954.
4. Ins. by Notfn. No.F-1-45/58-D, (SO 115), dt. 4-1-1961.
Drugs and Cosmetics Rules 1945
55
1[40. Procedure for the import of drugs. (1) If the Customs Collector has reason
to doubt whether any drugs comply with the provisions of Chapter III of the Act and
Rules thereunder he may, and if requested by an officer appointed for this purpose by
the Central Government shall, take samples of any drugs in the consignment and
forward them to the Director of the laboratory appointed for this purpose by the
Central Government and may detain the drugs in the consignment of which samples
have been taken until the report of the Director of the said laboratory or any other
officer empowered by him on this behalf, subject to the approval of the Central
Government, on such samples is received:
Provided that if the importer gives an undertaking in writing not to dispose of the
drugs without the consent of the Customs Collector and to return the consignment or
such portion thereof as may be required, the Customs Collector shall make over the
consignment to the importer.
(2) If an importer who has given an undertaking under the proviso to sub-rule (1)
is required by the Customs Collector to return the consignment or any portion thereof
he shall return the consignment or portion thereof within ten days of receipt of the
notice.]
2
[41. (1) If the Director of the laboratory appointed for the purpose by the Central
Government or any other officer empowered by him on this behalf, subject to the
approval of the Central Government, reports to the Customs Collector that the
samples of any drug in a consignment are not of standard quality, or that the drug
contravenes in any other respect the provisions of Chapter III of the Act or the Rules
thereunder and that the contravention is such that it cannot be remedied by the
importer, the Customs Collector shall communicate the report forthwith to the
importer who shall, within two months of his receiving the communication either
export all the drugs of that description in the consignment, to the country in which
they were manufactured or forfeit them to the Central Government which shall cause
them to be destroyed :
Provided that the importer may within fifteen days of receipt of the report make a
representation against the report to the Customs Collector, and the Customs Collector
shall forward the representation with a further sample to the licensing authority, who
after obtaining, if necessary, the report of the Director of the Central Drugs
Laboratory, shall pass orders thereon which shall be final.
3
[(2) If the Director of the laboratory appointed for the purpose by the Central
Government or any other officer empowered by him on this behalf, subject to the
approval of the Central Government reports to the Customs Collector that the samples
of any drug contravene in any respect the provisions of Chapter III of the Act or the
Rules thereunder and that the contravention is such that it can be remedied by the
importer, the Customs Collector shall communicate the report forthwith to the
importer and permit him to import the drug on his giving an undertaking in writing
not to dispose of the drug without the permission of the officer authorised in this
behalf by the Central Government.]]
4[* * * * *]
1. Subs. by Notifn. 1-99/52-D.S., dated 3-11-1953.
2. Subs. by Notfn. No. F. 7-7/47-D, dt. 5-1-1954.
3. Ins. by Notfn. No. 7-11/47-D, dt. 5-10-1951.
4. Rule 42 omitted by Notfn. No. F. 1-9/52-DS., dt. 3-11-1953.
Drugs and Cosmetics Rules 1945
56
43. The drugs specified in Schedule D shall be exempt from the provisions of
Chapter III of the Act and of the Rules made thereunder to the extent, and subject to
the conditions specified in that Schedule.
1
[43A. No drug shall be imported into India except through one of the following
places, namely:
Freozepore Cantonment and Amritsar Railway Stations:
In respect of drugs imported by rail across the frontier with Pakistan.
Ranaghat, Bongaon and Mohiassan Railways Stations:
In respect of drugs imported by rail across the frontier with Bangladesh.
5
[Petrapole Road in West Bengal, Sutarkandi in Assam, Old Raghna Bazar and Agartala in
Tripura :
In respect of drugs imported by Road from Bangladesh;]
2
[Raxaul:
In respect of drugs imported by road and railway lines connecting Raxaul in India
and Birganj in Nepal;]
4
[Chennai, Kolkata, Mumbai, Cochin, Nhava Sheva, Kandla and Inland Container
Depots at Tuglakabad and Patparganj in Delhi and Tuticorin in Tamil Nadu and
Marmugao port in Goa and Visakhapatnam in Andhra Pradesh:
In respect of drugs imported by sea into India;
Chennai, Kolkata, Mumbai, Delhi,Ahmedabad, Hyderabad, Goa, Bengaluru and
Visakhapatnam:
in respect of drugs imported by air into India.]
4
[43-B. Drugs, consignments of which are in transit through India to foreign
countries and which shall not be sold or distributed in India shall be exempted from
the requirements of Chapter III of the Drugs and Cosmetics Act, 1940 (23 of 1940)
and the Rules made thereunder:
Provided that if the Government of the countries to which the drugs are consigned
regulate their import by the grant of import licences, the importer shall at the time of
import into India, produce such import licences.]
1. Subs. by G.S.R 478 (E), dt. 6-8-1981. Earlier Ins. by Notfn No. F.7/7/47-D. dt. 5-1-1954.
2. Ins. by G.S.R 120 (E), dt. 5-3-1998.
3. Sub. by G.S.R 532 (E), dt. 18-05-2016. Earlier sub. by G.S.R 575 (E), dt. 17-11-2012, G.S.R 101 (E), dt.
18-2-2011, G.S.R 45 (E), dt. 21-1-2010, G.S.R 504 (E), dt. 18-7-2002, G.S.R 647 (E), dt. 28-10-1998.
4. Added by Notfn. No. E. 1-60/D, (SO 1056) dt. 19-3-1964.
5. Ins. by G.S.R. 116 (E), 24-01-2009.
Drugs and Cosmetics Rules 1945
57
PART V
1
[GOVERNMENT ANALYSTS, INSPECTORS, LICENSING
AUTHORITIES AND CONTROLLING AUTHORITIES]
2
[44. Qualifications of Government Analyst.
Government Analyst under the Act shall be a person who
A person appointed as a
(a) is a graduate in medicine or science or pharmacy or Pharmaceutical
Chemistry of a
3
[University established in India by law or has an equivalent
qualification recognized and notified by the Central Government for such
purpose] and has had not less than five years‘ post-graduate experience in the
testing of drugs in a laboratory under control of (i) a Government Analyst
appointed under the Act, or (ii) the head of an Institution or testing laboratory
approved for the purpose by the appointing authority,
4
[or has completed two
years‘ training on testing of drugs, including items stated in Schedule C, in
Central Drugs Laboratory], or
(b) possesses a post-graduate degree in medicine or science or pharmacy
or Pharmaceutical chemistry of a
3
[University established in India by law or
has an equivalent qualification recognized and notified by the Central
Government for such purpose] or possesses the Associateship Diploma of the
Institution of Chemists (India) obtained by passing the said examination with
‗Analysis of Drugs and Pharmaceuticals‘ as one of the subjects and has had
after obtaining the said post-graduate degree or diploma not less than three
years‘ experience in the testing of drugs in a laboratory under the control of (i)
a Government Analyst appointed under the Act, or (ii) the head of an
Institution or testing laboratory approved for the purpose by the appointing
authority
4
[or has completed training on testing of drugs, including items stated
in Schedule C, in Central Drugs Laboratory]:
Provided that-
4
[(i) for purpose of examination of items in Schedule C,-
(ia) the persons appointed under clause (a) or (b) and having degree in
Medicine, Physiology, Pharmacology, Microbiology, Pharmacy should
have experience or training in testing of said items in an institution or
laboratory approved by the appointing authority for a period of not less than
six months;
(ib) the person appointed under clause(a) or (b) but not having degree in the
above subjects should have experience or training in testing of said
Schedule C drugs for a period of not less than three years in an institution or
laboratory approved by the appointing authority or have completed two
years training on testing of drugs including items stated in Schedule C in
Central Drugs Laboratory;]
1. Subs. by G.S.R 443 (E), dt. 12-4-1989.
2. Subs. by G.S.R. No. 1427, dt. 22-10-1977.
3. Subs. by G.S.R. 71(E), dt 30.1.1987.
4. Ins. by G.S.R 697(E) dt. 26-10-1995.
Drugs and Cosmetics Rules 1945
58
(ii) for a period of four years from the date on which Chapter IV of the Act
takes effect in the States, persons whose training and experience are regarded
by the appointing authority as affording, subject to such further training, if any,
as may be considered necessary, a reasonable guarantee of adequate knowledge
and competence, may be appointed as Government Analysts. The persons so
appointed may, if the appointing authority so desires, continue in service after
the expiry of the said period of four years;
(iii) no person who is engaged directly or indirectly in any trade or business
connected with the manufacture of drugs shall be appointed as a Government
Analyst for any area:
Provided further that for the purpose of examination of Anti-sera, Toxoid and
Vaccines and Diagnostic Antigens for Veterinary use, the person appointed shall be a
person who is a graduate in Veterinary Science, or general science, or medicine or
pharmacy and has had not less than five years‘ experience in the standardization of
biological products or person holding a post-graduate degree in Veterinary Science,
or general science, or medicine or pharmacy or pharmaceutical chemistry with an
experience of not less than three years in the standardization of biological products :
Provided also that persons, already appointed as Government Analysts may
continue to remain in service, if the appointing authority so desires, notwithstanding
the fact that they do not fulfil the qualifications as laid down in clause (a), clause (b)
or the preceding proviso.
45. Duties of Government Analysts.−(1) The Government Analyst shall cause to
be analysed or tested such samples or drugs
1
[and cosmetics] as may be sent to
him by Inspectors or other persons under the provisions of Chapter IV of the Act and
shall furnish reports of the results of test or analysis in accordance with these Rules.
(2) A Government Analyst shall from time to time forward to the Government
reports giving the result of analytical work and research with a view to their
publication at the discretion of Government.
46. Procedure on receipt of sample.−On receipt of a package from an Inspector
containing a sample for test or analysis, the Government Analyst shall compare the
seals on the packet
2
[or on portion of sample or container] with the specimen
impression received separately and shall note the condition of the seals on the
3
[packet or on portion of sample or container]. After the test or analysis has been
completed, he shall forthwith supply to the Inspector a report in triplicate in Form 13
of the result of the test or analysis, together with full protocols of the tests or analysis
applied:
1. Ins. by S.O. 2139 dt. 5-6-1972.
2. Ins. by G.S.R. 59(E), dt. 7-2-1995.
3. Subs.by G.S.R. 59(E),dt. 7-2-1995.
Drugs and Cosmetics Rules 1945
59
1
[Explanation. It shall be deemed to be full and sufficient compliance with the
requirement of the rule in respect of the supply of ―protocols of the tests or analysis
applied‖, if
(1) for pharmacopoeial drug, where the tests or methods of analysis
prescribed in the official pharmacopoeia are followed, references to the specific
tests or analysis in the pharmacopoeias are given in the report;
(2) for patent or proprietary medicines for which the tests and methods
prescribed in any of the official pharmacopoeias are applicable and are
followed, references to the specific tests or analysis in the pharmacopoeias are
given in the report;
(3 )for patent or proprietary medicines containing pharmacopoeial drugs for
which the official tests or analysis or methods of assays are modified and
applied, a description of the actual tests or, as the case may be, analysis or
methods of assays so applied is given in the report;
(4) for patent or proprietary medicines for which no pharmacopoeial tests or
methods of analysis are available or can be applied but for which tests or
methods of analysis given in standard books or journals are followed, a
description of such tests or methods of analysis applied together with the
reference to the relevant books or journals from which the tests or methods of
analysis have been adopted, is given in the report;
(5) for those drugs for which methods of test are not available and have
been evolved by the Government Analyst, a description of tests applied is
given in the report.]
47. Report of result of test or analysis. An application from a purchaser for test
or analysis of a drug under section 26 of the Act shall be made in Form 14 A and the
report of test or analysis of the drug made on such application shall be supplied to the
applicant in Form 14B.
48. Fees. The fees to be paid by a person submitting to the Government
Analyst under section 26 of the Act for test or analysis of a drug
3
[or cosmetic]
purchased by him shall be those specified in Schedule B.
2
Previous and next
Questions people ask
Is rule 37 of the Drugs and Cosmetics Rules, 1945 still in force?
No repeal of the Drugs and Cosmetics Rules, 1945 is recorded.